progenitorlifesciences.com
Contate-nos
Sobre companhia
Progenitor was born on the Matisse Reprogramming System Technology for the generation of highly pluripoptent induced pluripotent stem cells. Using this technology, progenitor developed methods for immune cell differentiation, sparking their interest in the Cellular Immunotherapy. Scientists have discovered new methods for cancer cell targeting using chimeric antigen receptor (CAR) constructs, that when paired with the body’s killing immune cells, can be a potent therapy for previously immuno-evasive cancers.
US
Desconhecido
Empresa não verificada
Transparência de negócios
- Não verificou as informações da empresa
- Peça avaliações aos seus clientes
- Não respondeu a comentários negativos